A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial

This study is titled “A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised double-blind placebo-controlled trial” explored the effectiveness of a synbiotic preparation (SIM01) in alleviating symptoms of Post-acute COVID-19 syndrome (PACS)​​. PACS, a condition affecting over 65 million individuals globally, presents with a range of debilitating symptoms that persist for weeks to years following SARS-CoV-2 infection. Commonly affecting the respiratory, gastrointestinal, and neuropsychiatric systems, PACS significantly impacts daily life. This study focused on addressing the lack of effective treatments for PACS, particularly exploring the role of gut microbiome modulation​​. The study involved 463 patients…